US 10,888,567 B2
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
Brian Desmond Palmer, Auckland (NZ); Lai Ming Ching, Auckland (NZ); and Swarnalatha Akuratiya Gamage, Auckland (NZ)
Assigned to Auckland UniServices Limited, Auckland (NZ)
Appl. No. 15/503,210
Filed by AUCKLAND UNISERVICES LIMITED, Auckland (NZ)
PCT Filed Aug. 12, 2015, PCT No. PCT/IB2015/056129
§ 371(c)(1), (2) Date Feb. 10, 2017,
PCT Pub. No. WO2016/024233, PCT Pub. Date Feb. 18, 2016.
Claims priority of application No. 628688 (NZ), filed on Aug. 13, 2014.
Prior Publication US 2017/0224701 A1, Aug. 10, 2017
Int. Cl. A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/444 (2006.01); A61K 31/519 (2006.01); A61K 31/437 (2006.01); C07D 498/04 (2006.01); A61K 31/4745 (2006.01); A61K 31/423 (2006.01)
CPC A61K 31/5377 (2013.01) [A61K 31/423 (2013.01); A61K 31/437 (2013.01); A61K 31/444 (2013.01); A61K 31/4745 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); C07D 498/04 (2013.01)] 4 Claims
 
1. 6-chloro-5-fluoroisoxazolo [5,4-b]pyridin-3-amine or a pharmaceutically acceptable salt thereof.